Clinical Trial Update: The Effect of Rosuvastatin and Olmesartan on the Progression of Coronary Atherosclerotic Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial from Samsung Medical Center evaluates whether rosuvastatin with olmesartan can slow progression of coronary artery disease; the study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Olmesartan (olmesartan)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Coronary Syndrome | Phase 2 | Status: UNKNOWN